NEWPHARMA GROUP
ActiveSummary
NEWPHARMA GROUP has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €86.3m and a net result of €138,686. Equity is growing by ~3.8% per year across the filed fiscal years. Its solvency ranks better than 78% of 72 sector peers (fiscal year 2026). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 7 accounts on average 23 days before the deadline; the sector median for financial year 2024 is 9 days before the deadline, and 32% of the sector filed late.
Checked, nothing found (2)
History
On 7 November 2017, NEWPHARMA GROUP was incorporated by Korys Investments and Etablissementen Franz Colruyt, with a starting capital of EUR 62,000.12 Since 2018 the company has been called Newpharma Group.3 The registered office moved to Luik in 2018, to Liège in 2018 and to Wandre in 2026.345 The capital was increased 4 times between 2018 and 2025, most recently to EUR 95 million.678 4 companies were merged into the company between 2019 and 2025, including SKYCO and Smartvalue.91011 Of the 13 current board members, Korys Business Services I NV has served longest, since 2017.12
- 1Crossroads Bank for Enterprises
- 2Belgian State Gazette, 20-11-2017
- 3Belgian State Gazette, 08-02-2018
- 4Belgian State Gazette, 12-02-2018
- 5Belgian State Gazette, 29-06-2026
- 6Belgian State Gazette, 15-01-2018
- 7Belgian State Gazette, 07-04-2023
- 8Belgian State Gazette, 04-04-2025
- 9Belgian State Gazette, 27-06-2019
- 10Belgian State Gazette, 20-08-2019
- 11Belgian State Gazette, 20-11-2025
- 12Belgian State Gazette, 22-01-2018
Go further with this company
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2026, full schema, statutory accounts
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 70, Activities of head offices; management consultancy activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
- 2026 Turnover +684%, Staff (FTE) +157% on 2025. Merger absorbing Smartvalue, effective 31-10-2025.
- 2025 Net result +97% on 2024. The previous fiscal year ran 15 months, this one 12.
| Line | 2021 | 2022 | 2024 | 2025 | 2026 | Change |
|---|---|---|---|---|---|---|
| Operating income70/76A | €4.2m | €4.1m | €8.6m | €7.9m | €63.5m | ▲ 702% |
| Turnover70 | €4.1m | €3.9m | €8.4m | €7.8m | €60.9m | ▲ 684% |
| Own construction capitalised72 | - | - | - | - | €2.1m | - |
| Other operating income74 | €82,988 | €152,784 | €180,077 | €148,107 | €485,358 | ▲ 228% |
| Non-recurring operating income76A | - | - | €76,077 | - | - | - |
| Operating charges60/66A | €4.6m | €6.0m | €9.2m | €7.8m | €62.9m | ▲ 707% |
| Goods for resale, raw materials and consumables60 | - | - | - | - | €1.3m | - |
| Purchases600/8 | - | - | - | - | €1.3m | - |
| Change in stocks: decrease (increase)609 | - | - | - | - | -€42,367 | - |
| Services and other goods61 | €2.3m | €2.7m | €4.5m | €4.3m | €47.9m | ▲ 1,016% |
| Remuneration, social security and pensions62 | €2.2m | €2.7m | €4.1m | €3.2m | €10.8m | ▲ 239% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €141,568 | €377,629 | €499,509 | €405,204 | €3.0m | ▲ 630% |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | - | €119,063 | €129,559 | -€85,177 | -€69,569 | ▲ 18.3% |
| Other operating charges640/8 | €3,975 | €3,121 | €5,103 | €2,084 | €46,955 | ▲ 2,153% |
| Operating profit (loss)9901 | -€383,890 | -€1.9m | -€599,106 | €117,232 | €607,641 | ▲ 418% |
| Financial income75/76B | €12,005 | €1,538 | €161,512 | €438,036 | €21,861 | ▼ 95.0% |
| Recurring financial income75 | €12,005 | €1,538 | €161,512 | €438,036 | €21,861 | ▼ 95.0% |
| Income from financial fixed assets750 | - | - | €0 | €188,036 | €9,417 | ▼ 95.0% |
| Income from current assets751 | €6,970 | €1,511 | €161,512 | €250,000 | - | - |
| Other financial income752/9 | €5,035 | €27 | €0 | €0 | €12,444 | - |
| Financial charges65/66B | €354,745 | €438,573 | €788,472 | €593,060 | €489,031 | ▼ 17.5% |
| Recurring financial charges65 | €354,745 | €438,559 | €788,472 | €593,060 | €489,031 | ▼ 17.5% |
| Debt charges650 | €349,085 | €435,001 | €715,368 | €585,619 | €472,344 | ▼ 19.3% |
| Other financial charges652/9 | €5,660 | €3,558 | €73,105 | €7,441 | €16,686 | ▲ 124% |
| Non-recurring financial charges66B | - | €14 | €0 | - | - | - |
| Profit (loss) for the period before taxes9903 | -€726,630 | -€2.3m | -€1.2m | -€37,793 | €140,471 | ▲ 472% |
| Income taxes67/77 | €190 | €52,660 | €10,884 | €4,468 | €1,785 | ▼ 60.0% |
| Taxes670/3 | €190 | €52,660 | €10,884 | €4,535 | €10,916 | ▲ 141% |
| Tax adjustments and reversals of tax provisions77 | - | - | - | €68 | €9,131 | ▲ 13,427% |
| Profit (loss) for the period9904 | -€726,820 | -€2.4m | -€1.2m | -€42,260 | €138,686 | ▲ 428% |
| Profit (loss) for the period to be appropriated9905 | -€726,820 | -€2.4m | -€1.2m | -€42,260 | €138,686 | ▲ 428% |
| Line | 2021 | 2022 | 2024 | 2025 | 2026 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €88.3m | €96.0m | €99.2m | €101.1m | €108.6m | ▲ 7.4% |
| Fixed assets21/28 | €86.6m | €87.5m | €93.1m | €94.0m | €101.8m | ▲ 8.3% |
| Intangible fixed assets21 | €47,760 | €33,036 | €31,151 | €12,499 | €3.2m | ▲ 25,377% |
| Tangible fixed assets22/27 | €3.9m | €4.8m | €4.2m | €3.9m | €6.4m | ▲ 65.1% |
| Plant, machinery and equipment23 | - | - | - | - | €262,633 | - |
| Furniture and vehicles24 | €17,655 | €14,034 | €9,507 | €16,346 | €17,989 | ▲ 10.1% |
| Other tangible fixed assets26 | €3.5m | €4.8m | €4.2m | €3.9m | €6.1m | ▲ 58.4% |
| Assets under construction and advance payments27 | €403,231 | €0 | €0 | - | €2,209 | - |
| Financial fixed assets28 | €82.6m | €82.6m | €88.9m | €90.1m | €92.2m | ▲ 2.3% |
| Affiliated companies280/1 | €82.6m | €82.6m | €88.9m | €90.1m | €92.2m | ▲ 2.3% |
| Participating interests280 | €82.6m | €82.6m | €88.9m | €90.1m | €92.2m | ▲ 2.3% |
| Other financial fixed assets284/8 | - | €100 | €100 | €100 | €200 | ▲ 100% |
| Shares284 | - | €100 | €100 | €100 | €0 | ▼ 100% |
| Amounts receivable and cash guarantees285/8 | - | - | - | - | €200 | - |
| Current assets29/58 | €1.7m | €8.5m | €6.1m | €7.1m | €6.8m | ▼ 4.0% |
| Amounts receivable after more than one year29 | - | - | €0 | - | - | - |
| Other amounts receivable291 | - | - | €0 | - | - | - |
| Stocks and contracts in progress3 | - | - | - | - | €131,507 | - |
| Stocks30/36 | - | - | - | - | €131,507 | - |
| Raw materials and consumables30/31 | - | - | - | - | €131,507 | - |
| Amounts receivable within one year40/41 | €1.6m | €8.4m | €6.0m | €7.0m | €6.3m | ▼ 10.5% |
| Trade receivables40 | €1.4m | €3.2m | €954,436 | €744,121 | €6.0m | ▲ 702% |
| Other amounts receivable41 | €198,686 | €5.2m | €5.1m | €6.3m | €304,320 | ▼ 95.1% |
| Cash at bank and in hand54/58 | €83,971 | €8,602 | €36,661 | €1,214 | €21,524 | ▲ 1,673% |
| Deferred charges and accrued income490/1 | €26,207 | €46,013 | €60,059 | €72,233 | €373,718 | ▲ 417% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €88.3m | €96.0m | €99.2m | €101.1m | €108.6m | ▲ 7.4% |
| Equity10/15 | €63.4m | €61.0m | €79.7m | €86.7m | €86.3m | ▼ 0.5% |
| Contributions10/11 | €67.5m | €67.5m | €87.5m | €86.7m | €86.7m | = |
| Capital10 | €67.5m | €67.5m | €87.5m | €86.7m | €86.7m | = |
| Issued capital100 | €67.5m | €67.5m | €87.5m | €86.7m | €86.7m | = |
| Reserves13 | - | - | - | - | €0 | - |
| Non-distributable reserves130/1 | - | - | - | - | €0 | - |
| Reserves not available under the articles1311 | - | - | - | - | €0 | - |
| Distributable reserves133 | - | - | - | - | €0 | - |
| Profit (loss) carried forward14 | -€4.1m | -€6.5m | -€7.8m | -€42,262 | -€493,357 | ▼ 1,067% |
| Investment grants15 | - | - | - | - | €10,440 | - |
| Provisions and deferred taxes16 | - | €119,063 | €248,621 | €163,444 | €93,875 | ▼ 42.6% |
| Provisions for liabilities and charges160/5 | - | €119,063 | €248,621 | €163,444 | €93,875 | ▼ 42.6% |
| Other liabilities and charges164/5 | - | €119,063 | €248,621 | €163,444 | €93,875 | ▼ 42.6% |
| Amounts payable17/49 | €24.9m | €34.9m | €19.2m | €14.2m | €22.2m | ▲ 56.2% |
| Amounts payable after more than one year17 | €16.1m | €14.7m | €7.1m | €9.0m | €6.8m | ▼ 24.5% |
| Financial debts170/4 | €16.1m | €14.7m | €7.1m | €9.0m | €6.8m | ▼ 24.5% |
| Credit institutions173 | €8.8m | €7.5m | €0 | - | - | - |
| Other loans174 | €7.3m | €7.2m | €7.1m | €9.0m | €6.8m | ▼ 24.5% |
| Amounts payable within one year42/48 | €8.5m | €19.8m | €11.9m | €5.1m | €15.3m | ▲ 202% |
| Current portion of amounts payable after more than one year42 | €1.3m | €1.3m | €0 | €2.1m | €2.2m | ▲ 2.9% |
| Financial debts43 | €4.9m | €14.7m | €4.2m | - | €3.0m | - |
| Credit institutions430/8 | - | - | €4.2m | - | €3.0m | - |
| Other loans439 | €4.9m | €14.7m | €0 | - | - | - |
| Trade debts44 | €2.0m | €3.2m | €1.1m | €2.1m | €8.6m | ▲ 314% |
| Suppliers440/4 | €2.0m | €3.2m | €1.1m | €2.1m | €8.6m | ▲ 314% |
| Taxes, remuneration and social security45 | €364,838 | €650,678 | €703,041 | €669,067 | €1.5m | ▲ 131% |
| Taxes450/3 | €85,306 | €118,388 | €55,369 | €31,066 | €76,681 | ▲ 147% |
| Remuneration and social security454/9 | €279,532 | €532,290 | €647,672 | €638,001 | €1.5m | ▲ 130% |
| Other amounts payable47/48 | - | €60,000 | €5.9m | €207,368 | €5,000 | ▼ 97.6% |
| Accrued charges and deferred income492/3 | €335,308 | €378,850 | €239,221 | €169,642 | €134,711 | ▼ 20.6% |
| Line | 2021 | 2022 | 2024 | 2025 | 2026 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€726,820 | -€2.4m | -€1.2m | -€42,260 | €138,686 | ▲ 428% |
| + Depreciation and write-downs630 | €141,568 | €377,629 | €499,509 | €405,204 | €3.0m | ▲ 630% |
| Operating cash flow (approximation) | -€585,252 | -€2.0m | -€737,442 | €362,943 | €3.1m | ▲ 753% |
| Investment in fixed assets (approximation) | - | -€1.3m | - | -€1.3m | -€10.7m | ▼ 717% |
| Change in cash | - | -€75,369 | - | -€35,447 | €20,310 | ▲ 157% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
29-06
State Gazette act
Registered officeRegistered-office move2 facts ▸
- Board meeting, 01-06-2026
- Registered-office move, Rue du Charbonnage 9, 4020 Wandre Belgique
20-11
State Gazette act
Capital & shares · Statutes amendment · RestructuringMerger · Accounting effect · Share cancellation7 facts ▸
- General meeting, 28-10-2025
- Merger, opération assimilée à la fusion par absorption, 31-10-2025
- Accounting effect, 01-04-2025
- Share cancellation, droits de souscription de parts bénéficiaires, 2090
- Statutes amendment
- Capital, €86.745.274
- Share class suppression, Suppression des classes d'actions existantes; toutes les actions confèrent désormais les mêmes droits
04-09
State Gazette act
RestructuringMerger · Accounting effect · Capital5 facts ▸
- Merger, fusion par absorption, 31-10-2025
- Accounting effect, 01-04-2025
- Capital, €86.745.274
- Capital
- Shareholding, sole shareholder
04-04
State Gazette act
Capital & shares · Statutes amendmentCapital increase · Capital decrease · Capital7 facts ▸
- General meeting, 21-03-2025
- Capital increase, €7.000.000
- Capital decrease, €7.754.726
- Capital, €86.745.274
- Statutes amendment
- Power of attorney
- Power of attorney
14-06
State Gazette act
Statutes amendment4 facts ▸
- General meeting, 14-12-2023
- Statutes amendment
- Statutes amendment
- Statutes amendment
20-10
State Gazette act
Appointment: EY Réviseurs d'Entreprises (commissaire aux comptes)Permanent representative: Gilles Jourquin2 facts ▸
- Auditor appointment, EY Réviseurs d'Entreprises (commissaire aux comptes)
- Permanent representative, Gilles Jourquin
Show earlier events
07-04
State Gazette act
Capital & shares · Statutes amendmentCapital increase · Capital · Power of attorney6 facts ▸
- General meeting, 28-03-2023
- Capital increase, €20.000.000
- Capital, €87.500.000
- Statutes amendment
- Power of attorney
- Resolution, Pouvoirs à l'organe d'administration
23-03
State Gazette act
Resignations: Etablissements Franz Colruyt SA, Korys Business Services I SA and 4 othersAppointments: Jef Colruyt, Stefaan Vandamme and 3 others · Permanent representative: Gilles Jourquin · Mandate compensation24 facts ▸
- General meeting, 20-01-2023
- Director resignation, Etablissements Franz Colruyt SA (director)
- Director resignation, Korys Business Services I SA (director)
- Director resignation, Korys Business Services II SA (director)
- Director resignation, Lisa Colruyt (director)
- Director resignation, Organisation - Management - Consultancy and Relations SRL (director)
- Director resignation, JGO SRL (director)
- Director appointment, Jef Colruyt (director)
- Director appointment, Stefaan Vandamme (director)
- Director appointment, Jo Willemyns (director)
- Director appointment, Stefan Goethaert (director)
- Director appointment, Kris Castelein (director)
- +12 further facts in this act
01-08
State Gazette act
Resignation: Korys Management SA (director)Permanent representatives: Thomas de Kempeneer and Jourquin Gilles4 facts ▸
- General meeting, 31/03/2022
- Director resignation, Korys Management SA (director)
- Permanent representative, Thomas de Kempeneer
- Permanent representative, Jourquin Gilles
26-10
State Gazette act
Reappointments: Korys Business Services I NV, Korys Management NV and 3 othersPermanent representatives: Dries Colpaert, Thomas De Kempeneer and 5 others · Appointments: Korys Business Services II NV (administrateur de classe a) and Lisa Marie Colruyt (administrateur de classe b) · Resignations: JGO SRL, OMCR SRL and 5 others27 facts ▸
- General meeting, 25-08-2021
- Statutes amendment
- Capital, €67.500.000
- Director reappointment, Korys Business Services I NV (administrateur de classe a)
- Permanent representative, Dries Colpaert
- Director reappointment, Korys Management NV (administrateur de classe a)
- Permanent representative, Thomas De Kempeneer
- Director reappointment, JGO SRL (administrateur fondateur)
- Permanent representative, Jérôme Gobesso
- Director reappointment, OMCR SRL (administrateur fondateur)
- Permanent representative, Olivier Witmeur
- Director reappointment, Etablissementen Franz Colruyt NV (administrateur de classe b)
- +15 further facts in this act
12-10
State Gazette act
Resignation: JGO SRL (managing director)Appointments: GJ Lifesciences Management SRL (managing director) and JGO SRL (director) · Permanent representatives: Gilles Jourquin and Jérôme Gobbesso · Mandate compensation7 facts ▸
- General meeting, 14-07-2021
- Director resignation, JGO SRL (managing director)
- Director appointment, GJ Lifesciences Management SRL (managing director)
- Permanent representative, Gilles Jourquin
- Mandate compensation, GJ Lifesciences Management SRL
- Director appointment, JGO SRL (director)
- Permanent representative, Jérôme Gobbesso
27-05
State Gazette act
Appointments: B.D.O Réviseurs d'entreprise, Marc HOFMAN and Dries ColpaertPermanent representatives: Cédric ANTONELLO, Marc HOFMAN and Dries Colpaert · Resignations: Dieter STRUYE (director) and Dries Colpaert (director)10 facts ▸
- General meeting, 05-01-2021
- Auditor appointment, B.D.O Réviseurs d'entreprise (commissaire pour les comptes statutaires)
- Permanent representative, Cédric ANTONELLO
- General meeting, 30-07-2020
- Director resignation, Dieter STRUYE (director)
- Director appointment, Marc HOFMAN (director)
- Permanent representative, Marc HOFMAN
- Director resignation, Dries Colpaert (director)
- Director appointment, Dries Colpaert (director)
- Permanent representative, Dries Colpaert
20-08
State Gazette act
RestructuringMerger · Accounting effect · Share cancellation7 facts ▸
- General meeting, 31/07/2019
- Merger, absorption, transfert
- Accounting effect, 01/01/2019
- Share cancellation, fusion sans création de nouvelles actions, article 726 du code des Sociétés
- Dissolution, 31-07-2019
- Power of attorney, Administrateurs du conseil d'administration de Newpharma Group
- Shareholding, 100%
27-06
State Gazette act
RestructuringMerger · Dissolution · Share cancellation10 facts ▸
- General meeting, 28-05-2019
- Merger, absorption, 01-01-2019
- Merger, absorption, 01-01-2019
- Dissolution, 28-05-2019
- Dissolution, 28-05-2019
- Share cancellation, Annulation des parts sociales des sociétés absorbées OPTIMIS et DEEP DIVE détenues par la société absorbante
- Accounting effect, 01-01-2019
- Power of attorney, Administrateurs du conseil d'administration de Newpharma Group
- Ownership, 100% du capital
- Ownership, 100% du capital
25-06
State Gazette act
RestructuringPermanent representatives: Dieter Struye, Jérôme Gobbesso and 4 others · Merger · Power of attorney20 facts ▸
- Board meeting, 11-06-2019
- Merger
- Board composition, ETABLISSEMENTEN FRANZ COLRUYT (director)
- Permanent representative, Dieter Struye
- Board composition, JGO (director)
- Permanent representative, Jérôme Gobbesso
- Board composition, KORYS BUSINESS SERVICES I NV (director)
- Power of attorney, COLFIMA
- Permanent representative, Dries Colpaert
- Board composition, ORGANISATION - MANAGEMENT - CONSULTANCY and RELATIONS (director)
- Permanent representative, Olivier Witmeur
- Board composition, KORYS MANAGEMENT (director)
- +8 further facts in this act
18-04
State Gazette act
RestructuringMerger · Capital · Accounting effect8 facts ▸
- Board meeting, 02-04-2019
- Merger
- Merger
- Capital, €67.500.000
- Capital, €18.600
- Capital, €18.600
- Accounting effect, 01-01-2019
- Merger
13-12
State Gazette act
Appointment: Etn Fr. Colruyt NV (director)Permanent representative: Dieter Struye3 facts ▸
- General meeting, 29-06-2018
- Director appointment, Etn Fr. Colruyt NV (director)
- Permanent representative, Dieter Struye
12-02
State Gazette act
Statutes amendmentRegistered-office move · Capital · Beneficiary shares7 facts ▸
- General meeting, 19-01-2018
- Registered-office move, 4020 Liège, rue du Charbonnage 10 boîte 2
- Statutes amendment
- Capital, €67.500.000
- Beneficiary shares, 2090, Réserve de Parts Bénéficiaires (Réserves Indisponibles/Onbeschikbare Reserve) serving as guarantee to third parties
- Share classes
- Shareholders agreement, Convention d'Actionnaires
08-02
State Gazette act
Registered office · Statutes amendmentName change · Registered-office move4 facts ▸
- General meeting, 19-01-2018
- Name change, Newpharma Group
- Registered-office move, Rue du Charbonnage 10, bus 2, 4020 Luik
- Statutes amendment
22-01
State Gazette act
Appointments: JGO SPRL (managing director) and Korys Business Services I NV (chair of the board)Permanent representatives: Jérôme Gobbesso, Colfima BVBA and Dries Colpaert6 facts ▸
- Board meeting, 18-12-2017
- Director appointment, JGO SPRL (managing director)
- Permanent representative, Jérôme Gobbesso
- Director appointment, Korys Business Services I NV (chair of the board)
- Permanent representative, Colfima BVBA
- Permanent representative, Dries Colpaert
15-01
State Gazette act
Appointments: JGO, ORGANISATION MANAGEMENT CONSULTANCY & RELATIONS and BDO BedrijfsrevisorenPermanent representatives: GOBBESSO Jérôme, WITMEUR Olivier and ANTONELLI Cédric · Capital increase · Bank account17 facts ▸
- General meeting, 18-12-2017
- Capital increase, €23.625.000
- Bank account, BE97 0018 2841 6149
- Share issue, winstbewijzen, 2090
- Statutes amendment
- Capital, €67.500.000
- Director appointment, JGO (class B director)
- Permanent representative, GOBBESSO Jérôme
- Director appointment, ORGANISATION MANAGEMENT CONSULTANCY & RELATIONS (class B director)
- Permanent representative, WITMEUR Olivier
- Auditor appointment, BDO Bedrijfsrevisoren (statutory auditor)
- Permanent representative, ANTONELLI Cédric
- +5 further facts in this act
15-01
State Gazette act
Capital & sharesCapital increase · Bank account · Statutes amendment9 facts ▸
- General meeting, 15-12-2017
- Capital increase, €43.813.000
- Bank account, BNP Paribas Fortis NV/SA, BE22 0018 2841 5947
- Statutes amendment
- Capital, €43.875.000
- Power of attorney, Luc MEEUS
- Power of attorney, Koen HOORNAERT
- Power of attorney, Lien WILLEMS
- Power of attorney, elke zaakvoerder van de Vennootschap
20-11
State Gazette act
IncorporationAppointments: Korys Business Services I (director) and Korys Management (director) · Permanent representatives: Colfima, COLPAERT Dries Antoon and DE KEMPENEER Thomas Jan François Germaine · Founding capital13 facts ▸
- Incorporation, 06-11-2017
- Founding capital, €62.000
- Bank account, BNP Paribas Fortis, BE14 0018 2540 2883
- Director appointment, Korys Business Services I (director)
- Permanent representative, Colfima
- Permanent representative, COLPAERT Dries Antoon
- Director appointment, Korys Management (director)
- Permanent representative, DE KEMPENEER Thomas Jan François Germaine
- Mandate compensation, Korys Business Services I
- Mandate compensation, Korys Management
- Founder liability, volledige oprichtersaansprakelijkheid
- Founder liability, eervoudige inschrijver
- +1 further facts in this act
Directors · office · real estate
Board 12
Show all 12 directors
4 not recently confirmed
Day-to-day management 1
Permanent representatives 5
2 not recently confirmed
Statutory auditor 1
1 establishment unit
1 parcel
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62113B0166/00V000 | Wallonia | 2.8 ha | - | - |
Linked by address, not proof of ownership
Mandate history
- Board
- Day-to-day management
- Statutory auditor
- not recently confirmed
- began earlier
| Name | Functions and periods |
|---|---|
| JGO |
|
| Korys Business Services I NV |
|
| Dries Colpaert |
|
| Marc Hofman |
|
| Etablissementen Franz Colruyt NV |
|
| Korys Business Services II NV |
|
| KORYS MANAGEMENT NV |
|
| Jef Colruyt |
|
| Jo Willemyns |
|
| Kris Castelein |
|
| Stefaan Vandamme |
|
| Stefan Goethaert |
|
| GJ LIFESCIENCES MANAGEMENT |
|
| EY Réviseurs d'entreprises |
|
| Korys Business Services I |
|
| Korys Management |
|
| ORGANISATION - MANAGEMENT- CONSULTANCY and RELATIONS |
|
| Colruyt Group |
|
| BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES |
|
| Etablissements Franz Colruyt SA |
|
| JGO SRL |
|
| Korys Business Services I SA |
|
| Korys Business Services II SA |
|
| Lisa Marie Colruyt |
|
| Organisation - Management - Consultancy and Relations SRL |
|
| KORYS MANAGEMENT |
|
| OMCR SRL |
|
| Dieter Struye |
|
Articles of association
Full purpose
La société a pour objet, tant en Belgique qu'à l'étranger, tant en son propre nom et pour son propre compte qu'au nom ou pour le compte de tiers, seule ou en coopération avec des tiers: 1. l'acquisition par voie de souscription, achat, contribution, fusion, coopération, intervention financière ou autre, d'un intérêt ou d'une participation dans toutes sociétés, entreprises, activités, institutions ou associations existantes ou futures soit en Belgique soit à l'étranger. 2. la gestion, la valorisation et la monétisation de ces intérêts ou participations ou droits et l'étude des opportunités d'investissement et de désinvestissement, ainsi que la participation directe ou indirecte dans la gestion, la direction, le contrôle et la liquidation des sociétés, entreprises, activités, institutions et associations dans lesquelles la société a un intérêt ou une participation ou tout autre droit 3. fournir tout conseil et assistance relatif à tous les aspects de la gestion sociétaire, à la gestion et à la direction des sociétés, entreprises, activités, institutions et associations dans lesquelles elle détient un intérêt ou une participation ou tout autre droit, et en général accomplir tout acte qui relève, entièrement ou partiellement, directement ou indirectement, des activités d'une société mère 4. l'achat, l'échange ou autrement l'acquisition, la vente, la location, le bail, le lotissement, la construction, la rénovation, la reconstruction de biens immobiliers ou non ou de droits sur des biens immobiliers, en Belgique et à l'étranger, ainsi que l'exécution de tous actes nécessaires, utiles ou opportuns la gestion et à l'exploitation d'un patrimoine immobilier de la société 5. l'achat, la vente, le transfert, la gestion, la monétisation et la valorisation de tous les titres. actions, obligations, fonds et droits de l'État et la réalisation de tous les actes ou actions nécessaires ou utiles à la gestion de ce patrimoine mobilier de la société; 6. le commerce dans le sens le plus large, de produits pharmaceutiques, parapharmaceutiques, d'optiques, d'acoustiques, de droguerie ou de parfumerie et de tous articles ou produits qui peuvent accessoirement être vendus dans les officines pharmaceutiques ou dans d'autres magasins, succursales et agences; 7. la production, la fabrication, l'industrialisation, et, de quelque manière que ce soit, la commercialisation, l'exploitation et la distribution, de tous les produits et services susmentionnés, directement ou indirectement; 8. l'achat, l'acquisition, la vente, l'aliénation, l'exploitation, l'utilisation, détenir ou concéder sous licence, la réalisation, la monétisation, la commercialisation et la gestion de tous les droits de propriété intellectuelle, droits de propriété et d'utilisation, brevets, marques, certifications, dessins, licences ou autres droits intellectuels ou autres droíts liés à toutes les activités susmentionnées et ceci au sens le plus large; 9. la conception, le développement, la mise en place et la commercialisation de technologies, de matériel et solutions informatiques, la mise en place de réseaux, la création de sites Web, et leur hébergement, ainsi que le service de maintenance de matériel et de solutions informatiques; 10. toutes les activités ayant un rapport direct ou indirect avec le secteur du transport, le secteur du traitement et de la manutention de documents et de marchandises, et notamment: toutes activités ayant directement ou indirectement trait au service de courrier, à l'enlèvement et à l'expédition de marchandises et de courrier, au groupement d'envois individuels pour l'expédition, au transport de courrier et de colis, à la distribution et la délivrance de marchandises et de courrier, en ce compris en tant que commissionnaire de transport, expéditeur ou courtier; toutes activités d'agence intérimaire et de fourniture de personnel temporaire; l'exploitation d'entrepôts, en ce compris l'entreposage des marchandises et leur dédouanement: l'exploitation, la vente et l'achat, la location et le bail ainsi que le leasing de tous moyens de transports et de tous accessoires propres à l'industrie des transports et à son équipement; tous les services de support de logistique et de conseil ainsi que les services de consultance relatifs aux activités décrites ci-dessus; les services liés au commerce électronique, dans le sens le plus large, contre paiement ou non. Dans I'hypothèse où l'exécution de certaines opérations serait soumise à certaines conditions préalables, l'exécution de ces opérations dépendra de la réalisation de ces conditions. La société peut: d'une façon générale accomplir toutes opérations financières, mobilières ou immobilières se rapportant directement ou indirectement à son objet ou qui seraient de nature à en faciliter la réalisation; se porter garant, octroyer des garanties, agir comme agent ou représentant, accorder des avances, octroyer des prêts et garanties, fournir des hypothèques ou d'autres titres, au profit de toute société, entreprise, association ou personne.
Structure & network
Owners and holdings
1 owner · 6 holdings · 7 subsidiaries in the treeChain of control
- KORYS
- Colruyt Group
- Sukhino
- NEWPHARMA GROUP
Highest known parent: KORYS. The sources do not say who stands above it.
Owners 1
-
100%
Holdings 6
-
100%
-
100%
-
100%
-
100%
- Smartvalue DistributionsubsidiaryEquity €21,929Result -€28,071100%
-
100%
Stated earlier (1)
An older source named these holdings; newer accounts no longer list them.
-
100%
All subsidiaries, including indirect ones 7
Companies in which this company or one of its subsidiaries holds more than half, or which it consolidates according to the LEI register.
- APOTHEEK BEAUJEAN CENTRUM 100%
- APOTHEEK NOORDERLAAN 100%
- MEGAPARA SASFR 100%
NEWPHARMA 100%1 subsidiary
- ApopharmaCH 65%
- Smartvalue Distribution 100%
- Z+PHARMA 100%
According to the annual accounts to 31-03-2026 of NEWPHARMA GROUP and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
84 connected companiesShow 80 more companies with a shared director
Acquisitions and mergers
4 transactionsCapital and shareholders
- Korys Investments 26,325 shares
- Etablissementen Franz Colruyt 17,550 shares
- Korys Investments 61 shares (98.4%)
- Etablissementen Franz Colruyt 1 share (1.6%)
The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 20-11-2025 Capital stated in 2 acts · 86,745,274 EUR · 67,500 shares
- 04-04-2025 Capital increase of 7,000,000 EUR · to 94,500,000 EUR · in cash
- 04-04-2025 Capital reduction of 7,754,726 EUR · to 86,745,274 EUR · to absorb losses
- 07-04-2023 Capital increase of 20,000,000 EUR · to 87,500,000 EUR
- 26-10-2021 Capital stated in 4 acts · 67,500,000 EUR · 67,500 shares
- 15-01-2018 Capital increase of 43,813,000 EUR · to 43,875,000 EUR · 43,813 new shares · in cash
- 15-01-2018 Capital increase of 23,625,000 EUR · to 67,500,000 EUR · 23,625 new shares
- 20-11-2017 Incorporation · 62,000 EUR · 62 shares
Similar companies · same sector, comparable size
Identification & contact
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.